Roivant, Ve­ra seek $100M+ rais­es as they look to fund drug hope­fuls

Two life sci­ences com­pa­nies — Roivant Sci­ences and Ve­ra Ther­a­peu­tics — are plan­ning to bring in at least $100 mil­lion in new cash soon.

Roivant an­nounced Wednes­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER